Cell cycle-associated kinases as targets for therapy in lung cancer

J Thorac Oncol. 2010 Dec;5(12 Suppl 6):S461-2. doi: 10.1097/01.JTO.0000391366.63882.30.

Author

D Ross Camidge¹

Affiliation

¹ Developmental Therapeutics and Thoracic Oncology Programs, University of Colorado, Colorado, USA. Ross.Camidge@ucdenver.edu

PMID: 21102239
DOI: 10.1097/01.JTO.0000391366.63882.30

No abstract available

MeSH terms

Cell Cycle / drug effects*
Clinical Trials as Topic
Cyclin-Dependent Kinases / antagonists & inhibitors*
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / metabolism
Protein Kinase Inhibitors / therapeutic use*

Substances

Protein Kinase Inhibitors
Cyclin-Dependent Kinases